Valuation: Takeda Pharmaceutical Company Limited

Market Cap 9,105B 57.04B 49.27B 46.35B 42.13B 79.24B 5,465B 80.4B 544B 213B 2,733B 214B 210B P/E 2027 *
46.5x
P/E 2028 * 29.7x
Enterprise Value 13,041B 81.7B 70.57B 66.4B 60.34B 113B 7,828B 115B 779B 305B 3,915B 307B 300B EV / Sales 2027 *
2.78x
EV / Sales 2028 * 2.7x
Free-Float
99.28%
Yield 2027 *
3.58%
Yield 2028 * 3.65%
1 day+3.43%
1 week+2.15%
Current month+3.43%
1 month+4.05%
3 months+8.05%
6 months+2.61%
Current year+17.93%
1 week 5,482
Extreme 5482
5,727
1 month 5,225
Extreme 5225
5,903
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer 56 31/12/2024
Director of Finance/CFO 48 31/03/2024
Chief Tech/Sci/R&D Officer 47 31/01/2022
Director TitleAgeSince
Director/Board Member 60 31/05/2015
Director/Board Member 73 31/12/2018
Director/Board Member 48 31/05/2024
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Sell

Pres., Global Supply & Quality

-20,363 0.0013%
10/08/26 Sell

Pres., Global Supply & Quality

-3,978 0.0002%
10/08/26 Sell

Chief Executive Officer

-89,090 0.0056%
Change 5-day change 1-year change 3-year change Capi.($)
+3.43%+2.15%+29.33%+28.45% 55.24B
+2.58%-0.12%+73.85%+122.09% 1,055B
+3.00%+4.13%+53.50%+56.84% 632B
+2.51%+2.94%+24.63%+71.47% 442B
+1.35%-2.17%+40.98%+41.50% 351B
+1.75%-0.24%+25.28%+40.46% 290B
+2.13%-0.32%+0.58%+10.77% 243B
+1.76%+2.99%+45.82%+62.98% 227B
+1.35%-3.53%-14.72%-52.63% 200B
+3.12%+5.61%+21.52%+88.96% 172B
Average +2.35%-1.42%+30.08%+47.09% 366.78B
Weighted average by Cap. +2.39%-1.86%+42.87%+67.03%

Financials

2027 *2028 *
Net sales 4,684B 29.34B 25.34B 23.85B 21.67B 40.76B 2,811B 41.36B 280B 110B 1,406B 110B 108B 4,758B 29.81B 25.75B 24.23B 22.02B 41.41B 2,856B 42.02B 284B 111B 1,429B 112B 109B
Net income 191B 1.19B 1.03B 971M 882M 1.66B 114B 1.68B 11.39B 4.46B 57.24B 4.49B 4.39B 313B 1.96B 1.69B 1.59B 1.45B 2.72B 188B 2.76B 18.69B 7.33B 93.98B 7.36B 7.2B
Net Debt 3,937B 24.66B 21.3B 20.04B 18.22B 34.26B 2,363B 34.76B 235B 92.13B 1,182B 92.6B 90.59B 3,736B 23.41B 20.22B 19.02B 17.29B 32.52B 2,243B 32.99B 223B 87.44B 1,122B 87.88B 85.97B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
18/08/26 JP¥5,702.00 +3.43% 4,655,200
17/08/26 JP¥5,513.00 -1.75% 2,529,900
14/08/26 JP¥5,611.00 +0.94% 4,376,500
13/08/26 JP¥5,559.00 -0.05% 2,954,100
12/08/26 JP¥5,562.00 -0.36% 3,284,000
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
5,702.00JPY
Average target price
6,450.19JPY
Spread / Average Target
+13.12%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock